• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Reactivity of acrolein produced by cancer cells: Application to selective cancer therapy

Research Project

Project/Area Number 21K05269
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 37010:Bio-related chemistry
Research InstitutionTokyo Institute of Technology

Principal Investigator

Pradipta Ambara  東京工業大学, 物質理工学院, 助教 (90631648)

Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2023: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2022: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2021: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Keywordsアクロレイン / アジド / プロドラッグ / がん治療 / 化学療法 / 環化付加反応 / クリック反応 / Acrolein / Azide / Prodrug / Cycloaddition / Cancer
Outline of Research at the Start

This applicant set out to utilize a bioorthogonal prodrug activation reaction based on the 1,3-dipolar cycloaddition between aryl azide and endogenous acrolein that is generally overproduced by cancer cells. If it succeeds, this method eliminates the need for pretreatments to accumulating exogenous enzymes or other activating agents on the cancerous tissues before prodrug administration, making it more realistic for practical application.

Outline of Final Research Achievements

Chemotherapy is essential in cancer treatment, but a significant challenge is that common cancer drugs also attack healthy cells, causing severe side effects. To address this problem, prodrug technology has been developed. Prodrugs are initially inactive and are designed to activate only in the specific environment of cancer cells. This research introduces a new type of prodrug that reacts only with acrolein, a metabolite overly produced by cancer cells. This means the prodrug only becomes active through a chemical reaction with acrolein, significantly reducing the impact on healthy cells. This approach does not require the addition of exogenous enzymes or activators, making it a safer and more practical option for use in treatment settings.

Academic Significance and Societal Importance of the Research Achievements

現在のがん化学療法で使用される抗がん剤は、正常細胞にも作用するため多くの副作用が生じる問題がある。これを解決するため、我々はがん細胞内でのみ活性化されるプロドラッグを設計した。このプロドラッグは、特定の化学反応によりがん組織でのみ抗がん活性分子を放出し、副作用のない効果的な治療を実現した。この技術は将来、がん治療へ応用されることで、患者の生活の質の向上と医療現場での治療選択肢の拡大に寄与すると期待される。

Report

(4 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • Research Products

    (52 results)

All 2024 2023 2022 2021 Other

All Journal Article (10 results) (of which Int'l Joint Research: 8 results,  Peer Reviewed: 9 results,  Open Access: 4 results) Presentation (36 results) (of which Int'l Joint Research: 2 results,  Invited: 10 results) Book (3 results) Remarks (2 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Metallic radionuclide-labeled tetrameric 2,6-diisopropylphenyl azides for cancer treatment2024

    • Author(s)
      Ode Yudai、Pradipta Ambara R.、Ishiwata Akihiro、Nambu Akihiro、Ohnuki Kazunobu、Mizuma Hiroshi、Haba Hiromitsu、Tanaka Katsunori
    • Journal Title

      Chemical Communications

      Volume: 60 Issue: 24 Pages: 3291-3294

    • DOI

      10.1039/d4cc00048j

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Anticancer approach by targeted activation of a global inhibitor of sialyltransferases with acrolein2024

    • Author(s)
      Kasahara Takatsugu、Chang Tsung-Che、Yoshioka Hiromasa、Urano Sayaka、Egawa Yasuko、Inoue Michiko、Tahara Tsuyoshi、Koji Morimoto、Pradipta Ambara R.、Tanaka Katsunori
    • Journal Title

      Chemical Science

      Volume: - Issue: 25 Pages: 9566-9573

    • DOI

      10.1039/d4sc00969j

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Therapeutic efficacy of <sup>211</sup>At-radiolabeled 2,6-diisopropylphenyl azide in mouse models of human lung cancer2023

    • Author(s)
      Ode Yudai、Pradipta Ambara R.、Ahmadi Peni、Ishiwata Akihiro、Nakamura Akiko、Egawa Yasuko、Kusakari Yuriko、Muguruma Kyohei、Wang Yang、Yin Xiaojie、Sato Nozomi、Haba Hiromitsu、Tanaka Katsunori
    • Journal Title

      Chemical Science

      Volume: 14 Issue: 30 Pages: 8054-8060

    • DOI

      10.1039/d3sc02513f

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] 有機合成反応を活用したがん診断2023

    • Author(s)
      Pradipta Ambara R、田中克典
    • Journal Title

      イメージングによる最先端医薬品・医療技術開発, 月刊誌「Precision Medicine」

      Volume: 6 Pages: 18-23

    • Related Report
      2022 Research-status Report
  • [Journal Article] Peptide/protein-mediated delivery of a ruthenium catalyst for in vivo tumor therapy2023

    • Author(s)
      Muguruma Kyohei, Imai Kyosuke, Pradipta Ambara R, Tanaka Katsunori
    • Journal Title

      Peptide Science: Proceeding of the Japanese Peptide Symposium

      Volume: 1 Pages: 125-126

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Comparison of “click-to-sense” assay with frozen section analysis using simulated surgical margins in breast cancer patients2022

    • Author(s)
      Kubo Anna、Tanei Tomonori、Pradipta Ambara R、Morimoto Koji、Fujii Motoko、Sota Yoshiaki、Miyake Tomohiro、Kagara Naofumi、Shimoda Masafumi、Naoi Yasuto、Motoyama Yuichi、Morii Eiichi、Tanaka Katsunori、Shimazu Kenzo
    • Journal Title

      European Journal of Surgical Oncology

      Volume: 48 Issue: 7 Pages: 1520-1526

    • DOI

      10.1016/j.ejso.2022.04.003

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] The Second-Generation Click-to-Sense Probe for Intraoperative Diagnosis of Breast Cancer Tissues Based on Acrolein Targeting2022

    • Author(s)
      Pradipta Ambara R.、Michiba Hiroyuki、Kubo Anna、Fujii Motoko、Tanei Tomonori、Morimoto Koji、Shimazu Kenzo、Tanaka Katsunori
    • Journal Title

      Bulletin of the Chemical Society of Japan

      Volume: 95 Issue: 3 Pages: 421-426

    • DOI

      10.1246/bcsj.20210387

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Targeted 1,3-dipolar cycloaddition with acrolein for cancer prodrug activation2021

    • Author(s)
      Pradipta, A. R., Ahmadi, P., Terashima, K., Muguruma, K., Fujii, M., Ichino, T., Maeda, S., Tanaka, K.
    • Journal Title

      Chem. Sci.

      Volume: - Issue: 15 Pages: 5438-5449

    • DOI

      10.1039/d0sc06083f

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Application of acrolein imines to organic synthesis, biofunctional studies, and clinical practice2021

    • Author(s)
      Pradipta, A. R., Tanaka, K.
    • Journal Title

      Chem. Rec.

      Volume: 21 Issue: 4 Pages: 646-662

    • DOI

      10.1002/tcr.202000146

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Biofunctional chemistry and reactivity of biogenic acrolein for cancer diagnosis and therapy2021

    • Author(s)
      Pradipta Ambara R.、Tanaka Katsunori
    • Journal Title

      Chemical Communications

      Volume: 57 Issue: 77 Pages: 9798-9806

    • DOI

      10.1039/d1cc03590h

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Presentation] Clinical synthetic chemistry: Rapid intraoperative diagnosis of breast cancer2023

    • Author(s)
      Pradipta Ambara R.
    • Organizer
      RIKEN-Academia Sinica-Tokyo Tech-NTHU Glycoscience Joint Meeting
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 生体内での有機合成化学による次世代医療2023

    • Author(s)
      Pradipta Ambara R
    • Organizer
      第6回 東工大応用化学系 次世代を担う若手シンポジウム
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] がん細胞内でのDiels-Alder反応によるプロドラッグ法の検討2023

    • Author(s)
      服部海斗, 道場皓之, Pradipta Ambara R, 田中克典
    • Organizer
      日本化学会第103春季年会
    • Related Report
      2022 Research-status Report
  • [Presentation] 生体寛容性人工金属触媒によるジアゾ化合物の反応性の検討2023

    • Author(s)
      奥村昂也, Pradipta Ambara R, 田中克典
    • Organizer
      日本化学会第103春季年会
    • Related Report
      2022 Research-status Report
  • [Presentation] アクロレインをトリガーとしたがん細胞内での水酸基脱保護反応の開発2023

    • Author(s)
      髙橋ゆりあ, 寺島一輝, Pradipta Ambara R, 田中克典
    • Organizer
      日本化学会第103春季年会
    • Related Report
      2022 Research-status Report
  • [Presentation] 分子内アザ電子環状反応によるがん細胞現地での天然物合成研究2023

    • Author(s)
      寺島一輝, Pradipta Ambara R, 田中克典
    • Organizer
      日本化学会第103春季年会
    • Related Report
      2022 Research-status Report
  • [Presentation] アクロレインとアジドの反応を利用した標的α線治療2023

    • Author(s)
      大出雄大, Pradipta Ambara R, 田中克典
    • Organizer
      日本化学会第103春季年会
    • Related Report
      2022 Research-status Report
  • [Presentation] がん代謝物をトリガーとした糖転移酵素阻害剤の活性化とがん治療2023

    • Author(s)
      笠原隆継, 張宗哲, 浦野清香, Pradipta Ambara R, 田中克典
    • Organizer
      日本化学会第103春季年会
    • Related Report
      2022 Research-status Report
  • [Presentation] がん細胞での選択的環化反応による新規タンパク質分解誘導の検討2023

    • Author(s)
      松嶋良真, Pradipta Ambara R, 田中克典
    • Organizer
      日本化学会第103春季年会
    • Related Report
      2022 Research-status Report
  • [Presentation] 生体内での有機合成化学による次世代医療2022

    • Author(s)
      Pradipta Ambara R
    • Organizer
      第12回 CSJ化学フェスタ2022
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] Biofunctional chemistry and reactivity of biogenic acrolein for cancer diagnosis and therapy2022

    • Author(s)
      Pradipta Ambara R
    • Organizer
      The 17th Joint Conference on Chemistry (JCC2022)
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] Biofunctional chemistry and reactivity of biogenic acrolein for cancer diagnosis and therapy2022

    • Author(s)
      Pradipta Ambara R
    • Organizer
      RIKEN - Taiwan National Chung Hsing University Symposium
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] がんが普遍的に過剰生産するアクロレイン代謝物:生組織でのカスケード反応によるがん診断・治療への応用2022

    • Author(s)
      Pradipta Ambara R
    • Organizer
      2022若手研究者のためのセミナー
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] Biofunctional chemistry and reactivity of biogenic acrolein for cancer diagnosis and therapy2022

    • Author(s)
      Pradipta Ambara R
    • Organizer
      The 15th International Conference on Cutting-Edge Organic Chemistry in Asia (ICCEOCA15)
    • Related Report
      2022 Research-status Report
    • Invited
  • [Presentation] Reactivity of Endogenous Acrolein: Application for Cancer-Specific Ubiquitination2022

    • Author(s)
      Pradipta Ambara R
    • Organizer
      新学術領域「ケモユビキチン 」第6回総括班会議
    • Related Report
      2022 Research-status Report
  • [Presentation] がんが普遍的に過剰生産するアクロレイン代謝物:生組織でのカスケード反応によるがん診断・治療への応用2022

    • Author(s)
      Pradipta Ambara R
    • Organizer
      基礎研究機構全体イベント
    • Related Report
      2022 Research-status Report
  • [Presentation] Reactivity of Endogenous Acrolein: Application for Proteolysis-Induced Cancer Treatment2022

    • Author(s)
      Pradipta Ambara R
    • Organizer
      The International Symposium in Tokyo 2022: Ubiquitin New Frontier “from Neo-Biology to Targeted Protein Degradation”
    • Related Report
      2022 Research-status Report
    • Int'l Joint Research
  • [Presentation] アクロレインの新規反応性に基づく糖転移酵素阻害剤の活性化2022

    • Author(s)
      笠原隆継, Chang Tsung C, 浦野清香, Pradipta Ambara R, 田中克典
    • Organizer
      第83回有機合成化学協会関東支部シンポジウム
    • Related Report
      2022 Research-status Report
  • [Presentation] アクロレインとアジドの環化付加反応に基づく糖転移酵素阻害剤の活性化2022

    • Author(s)
      笠原隆継, Pradipta Ambara R, 田中克典
    • Organizer
      第12回CSJ化学フェスタ2022
    • Related Report
      2022 Research-status Report
  • [Presentation] がんのアクロレインを用いた薬理活性複素環化合物の合成研究2022

    • Author(s)
      奥村昂也, Pradipta Ambara R, 田中克典
    • Organizer
      第12回CSJ化学フェスタ2022
    • Related Report
      2022 Research-status Report
  • [Presentation] アクロレインとの反応によるタンパク質の分解誘導がん治療2022

    • Author(s)
      松嶋良真, Pradipta Ambara R, 田中克典
    • Organizer
      第12回CSJ化学フェスタ2022
    • Related Report
      2022 Research-status Report
  • [Presentation] がん代謝物との反応を基盤とするプロドラッグ法2022

    • Author(s)
      寺島一輝, Pradipta Ambara R, 田中克典
    • Organizer
      第16回バイオ関連化学シンポジウム
    • Related Report
      2022 Research-status Report
  • [Presentation] がん代謝物との反応を基盤とした標的α線がん治療分子2022

    • Author(s)
      大出雄大, Pradipta Ambara R, 田中克典
    • Organizer
      創薬懇談会2022
    • Related Report
      2022 Research-status Report
  • [Presentation] がん代謝物との反応を基盤とした生体内天然物合成研究2022

    • Author(s)
      寺島一輝, Pradipta Ambara R, 田中克典
    • Organizer
      創薬懇談会2022
    • Related Report
      2022 Research-status Report
  • [Presentation] がんが普遍的に過剰生産するアクロレイン代謝物:生組織でのカスケード反応によるがん診断・治療への応用2021

    • Author(s)
      Pradipta Ambara R.
    • Organizer
      第8回慶應有機化学若手シンポジウム
    • Related Report
      2021 Research-status Report
    • Invited
  • [Presentation] Add Perseverance to Your Passion: The Long and Rocky Academia Pathway2021

    • Author(s)
      Pradipta Ambara R.
    • Organizer
      第11回 CSJ化学フェスタ 2021
    • Related Report
      2021 Research-status Report
    • Invited
  • [Presentation] Thriving in Your Research Career: My Personal Experience - Hints & Tips2021

    • Author(s)
      Pradipta Ambara R.
    • Organizer
      第12回 Tokyo Tech Indonesian Commitment Award 2021
    • Related Report
      2021 Research-status Report
    • Invited
  • [Presentation] がんが普遍的に過剰生産するアクロレイン代謝物:生組織でのカスケード反応によるがん診断・治療への応用2021

    • Author(s)
      Pradipta Ambara R.
    • Organizer
      Departmental Talk Kyushu University
    • Related Report
      2021 Research-status Report
    • Invited
  • [Presentation] Reactivity of Acrolein Released from Cancer Cells: Application for Selective Cancer Therapy and Diagnosis2021

    • Author(s)
      Pradipta Ambara R.
    • Organizer
      日本化学会第101春季年会
    • Related Report
      2021 Research-status Report
  • [Presentation] がん代謝物との反応を基盤とするプロドラッグ法2021

    • Author(s)
      Pradipta Ambara R.
    • Organizer
      第79回有機合成化学協会関東支部大岡山シンポジウム
    • Related Report
      2021 Research-status Report
  • [Presentation] がん代謝物との環化付加反応によるがん化学療法2021

    • Author(s)
      Pradipta Ambara R.
    • Organizer
      日本ケミカルバイオロジー学会 第15回年会
    • Related Report
      2021 Research-status Report
  • [Presentation] Reactivity of Endogenous Acrolein: Application for Cancer-Specific Ubiquitination2021

    • Author(s)
      Pradipta Ambara R.
    • Organizer
      新学術領域「ケモユビキチン 」第6回総括班会議
    • Related Report
      2021 Research-status Report
  • [Presentation] 生体内ディールス・アルダー反応を用いたプロドラック開発2021

    • Author(s)
      道場皓之, Pradipta Ambara R., 田中克典
    • Organizer
      日本化学会第102春季年会
    • Related Report
      2021 Research-status Report
  • [Presentation] がんで選択的に生じるジアゾ化合物を用いたアジリジンの合成2021

    • Author(s)
      奥村昂也, Pradipta Ambara R., 田中克典
    • Organizer
      日本化学会第102春季年会
    • Related Report
      2021 Research-status Report
  • [Presentation] がん代謝物との反応を基盤とした生体内天然化合物合成研究2021

    • Author(s)
      寺島一輝, Pradipta Ambara R., 田中克典
    • Organizer
      日本化学会第102春季年会
    • Related Report
      2021 Research-status Report
  • [Presentation] 糖転移酵素阻害剤のプロドラッグ2021

    • Author(s)
      笠原隆継, 張宗哲, Pradipta Ambara R., 田中克典
    • Organizer
      日本化学会第102春季年会
    • Related Report
      2021 Research-status Report
  • [Book] イメージングによる最先端医薬品・医療技術開発, 月刊誌「Precision Medicine」2023

    • Author(s)
      Pradipta Ambara R, 田中克典
    • Total Pages
      6
    • Publisher
      株式会社北陸館出版
    • Related Report
      2022 Research-status Report
  • [Book] 生体分子と疾患2022

    • Author(s)
      多根井智紀, Pradipta Ambara R, 田中克典
    • Total Pages
      208
    • Publisher
      化学同人
    • ISBN
      9784759813999
    • Related Report
      2022 Research-status Report
  • [Book] 生体分子と疾患, CSJ Current Review 392021

    • Author(s)
      多根井智紀, Pradipta Ambara R., 田中克典
    • Total Pages
      6
    • Publisher
      株式会社化学同人出版
    • Related Report
      2021 Research-status Report
  • [Remarks] がんに貼り付く極小サイズの分子接着剤

    • URL

      https://www.titech.ac.jp/news/2024/068611

    • Related Report
      2023 Annual Research Report
  • [Remarks] わずか窒素3原子でがんを見つけてα線治療

    • URL

      https://www.titech.ac.jp/news/2023/067051

    • Related Report
      2023 Annual Research Report
  • [Patent(Industrial Property Rights)] 腫瘍の治療剤2023

    • Inventor(s)
      永橋昌幸、三好康雄、田中克典、盛本浩二、プラディプタ アンバラ
    • Industrial Property Rights Holder
      永橋昌幸、三好康雄、田中克典、盛本浩二、プラディプタ アンバラ
    • Industrial Property Rights Type
      特許
    • Filing Date
      2023
    • Acquisition Date
      2023
    • Related Report
      2023 Annual Research Report

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi